"10.1371_journal.pone.0019262","plos one","2011-05-13T00:00:00Z","Richard A Rudick; M R Sandhya Rani; Yaomin Xu; Jar-Chi Lee; Jie Na; Jennifer Shrock; Anupama Josyula; Elizabeth Fisher; Richard M Ransohoff","Mellen Center for Multiple Sclerosis, Neurological Institute, Cleveland Clinic, Cleveland, Ohio, United States of America; Department of Neurosciences, Neuroinflammation Research Center, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, United States of America; Quantitative Health Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, United States of America; Department of Biomedical Engineering, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, United States of America","Conceived and designed the experiments: RAR RMR EF. Performed the experiments: MRSR JS AJ. Analyzed the data: RAR RMR EF YX J-CL JN. Wrote the paper: RAR RMR EF. Developed the macroarray assay and supervised the macroarray analyses: MRSR. Conceived and implemented data analysis plans, supervised data analyses and database implementation: YX. Provided database programmming: JN.","The authors have read the journal's policy and wish to declare the following conflicts: All authors received support (paid to institution) for this project via NIH-NINDS grant P50 NS 38667 (2004â€“2009), Project 4 P01NS38667. [Rudick Richard] RMR was PI for the P50 and PO1; RAR was director for Project 4. RAR: Consulting fees or honoraria: Biogen Idec, Novartis, Teva [Rudick, Richard], Millennium [Rudick, Richard], Genzyme-Bayer [Rudick, Richard],; Wyeth, Bayhill [Rudick, Richard], Pfizer Royalties: Informa Healthcare Travel expenses paid: Novartis [Rudick, Richard], Millenium [Rudick, Richard], Genzyme-Bayer [Rudick, Richard], Merck Serono [Rudick, Richard], Wyeth [Rudick, Richard], Pfizer. RMR: Consultancies (within 12 mos): Abbott, Biogen, Johnson & Johnson, Merck, Novartis, Pfizer, Teva Paid lectures (not speakers bureaus): Biogen Idec, grand rounds only, not promotional Grants/grants pending (paid to institution): NIH; NMSS; Biogen Idec; Chemocentryx EF: Consultancies: Biogen Idec, Genzyme, Millenium, Pfizer, Wyeth Grants/grants pending (paid to institution): Biogen, Genzyme, Millenium, Wyeth; NIH-NINDS. Honoraria: Biogen, Teva Travel expenses: Biogen, Genzyme, Millenium, Wyeth, Pfizer. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.","2011","05","Richard A Rudick","RAR",9,TRUE,3,3,6,3,TRUE,TRUE,FALSE,0,NA,FALSE
